Incidence of Skeletal-related Events Over Time from Solid Tumour Bone Metastases Reported in Randomised Trials Using Bone-modifying Agents
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology
Reference27 articles.
1. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials;Lipton;Cancer,2000
2. Effect of bisphosphonates on pain and quality of life in patients with bone metastases;Costa;Nat Clin Pract Oncol,2009
3. Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group;Theriault;J Clin Oncol,1999
4. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma;Henry;J Clin Oncol,2011
5. Continuing benefit of zoledronic acid in preventing skeletal complications in patients with bone metastases;Saad;Clin Genitourin Cancer,2007
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Review on effects and mechanisms of plant-derived natural products against breast cancer bone metastasis;Heliyon;2024-09
2. Factors associated with skeletal‐related events in patients with bone metastatic melanoma: A retrospective study of 481 patients;Journal of Surgical Oncology;2024-06-17
3. Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases;American Journal of Clinical Oncology;2024-01-11
4. Myelopathy as a Presentation of Cervical Spine Metastasis: A Case Report;Open Journal of Modern Neurosurgery;2024
5. Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312);Lung Cancer;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3